A simple, weight-based, extended-interval gentamicin dosage protocol for neonates

American Journal of Health-System Pharmacy

Volumn 62, Issue 15, 2005, Pages 1613-1616

  Hale, LaDonna S ^a,b   Durham, Christopher R ^c  

^a WICHITA STATE UNIVERSITY   (United States)

^b WESLEY MEDICAL CENTER   (United States)

^c WMC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CREATININE; GENTAMICIN;

ARTICLE; DRUG BLOOD LEVEL; DRUG COST; DRUG EFFICACY; DRUG SAFETY; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NECROTIZING ENTEROCOLITIS; NEPHROTOXICITY; NEWBORN INFECTION; PNEUMONIA; PRIORITY JOURNAL; SEPSIS; WEIGHT;

EID: 23044487176     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp040532     Document Type: Article

References (24)

1. Skopnik H, Wallraf R, Nies B et al. Pharmacokinetics and antibacterial activity of daily gentamicin. Arch Dis Child. 1992; 67:57-61.
2. Moore RD, Lietman PS, Smith CR. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis. 1987; 155:93-9.
3. Rybak MJ, Abate BJ, Kang SL et al. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Antimicrob Agents Chemother. 1999; 43:1549-55.
4. Ali MZ, Goetz MB. A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin Infect Dis. 1997; 24:796-809.
5. Rougier F, Claude D, Maurin M et al. Aminoglycoside nephrotoxicity: modeling, simulation, and control. Antimicrob Agents Chemother. 2003; 47:1010-6.
6. Davies MW, Cartwright DW. Gentamicin dosage intervals in neonates: longer dosage interval-less toxicity. J Paediatr Child Health. 1998; 35:577-80.
7. Murry KR, McKinnon PS, Mitrzyk B et al. Pharmacodynamic characterization of nephrotoxicity associated with once-daily aminoglycoside. Pharmacotherapy. 1999; 19:1252-60.
8. Raveh D, Kopyt M, Kite Y et al. Risk factors for nephrotoxicity in elderly patients receiving once-daily aminoglycosides. Q J Med. 2002; 95:291-7.
9. Hitt CM, Klepser ME, Nightingale CH et al. Pharmacoeconomic impact of once-daily aminoglycoside administration. Pharmacotherapy. 1997; 17:810-4.
10. Edson RS, Terrell CL. The aminoglycosides. Mayo Clin Proc. 1999; 74:519-28.
11. Preston SL, Briceland LL. Single daily dosing of aminoglycosides. Pharmacotherapy. 1995; 15:297-316.
12. Knoderer CA, Everett JA, Buss WF. Clinical issues surrounding once-daily aminoglycoside dosing in children. Pharmacotherapy. 2003; 23:44-56.
13. Turnidge J. Pharmacodynamics and dosing of aminoglycosides. Infect Dis Clin North Am. 2003; 17:503-28.
14. Chuck SK, Raber SR, Rodvold KA et al. National survey of extended-interval aminoglycoside dosing. Clin Infect Dis. 2000; 30:433-9.
15. Langlass TM, Mickle TR. Standard gentamicin dosage regimen in neonates. Am J Health-Syst Pharm. 1999; 56:440-3.
16. Lundergan FS, Glasscock GF, Kim EH et al. Once-daily gentamicin dosing in newborn infants. Pediatrics. 1999; 103:1228-34.
17. Thureen PJ, Reiter PD, Gresores A et al. Once- versus twice-daily gentamicin dosing in neonates >/=34 weeks' gestation: cost-effectiveness analyses. Pediatrics. 1999; 103:594-8.
18. Ohler KH, Menke JA, Fuller L. Use of higher dose extended interval aminoglycosides in a neonatal intensive care unit. Am J Perinatol. 2000; 17:285-90.
19. Agarwal G, Rastogi A, Pyati S et al. Comparison of once-daily versus twice-daily gentamicin dosing regimens in infants > or = 2500 g. J Perinatol. 2002; 22:268-74.
20. DiCenzo R, Forrest A, Slish JC et al. A gentamicin pharmacokinetic population model and once-daily dosing algorithm for neonates. Pharmacotherapy. 2003; 23:585-91.
21. Hansen A, Forbes P, Arnold A et al. Once-daily gentamicin dosing for the preterm and term newborn: proposal for a simple regimen that achieves target levels. J Perinatol. 2003; 23:635-9.
22. Young TE, Mangum B. Neofax 2003. 16th ed. Raleigh, NC: Acorn; 2003.
23. Murphy JE. Prediction of gentamicin peak and trough concentrations from six extended-interval dosing protocols for neonates. Am J Health-Syst Pharm. 2005; 62:823-7.
24. Hayani KC, Hatzopoulos FK, Frank AL et al. Pharmacokinetics of once-daily dosing of gentamicin in neonates. J Pediatr. 1997; 131:76-80.